The GMR Clinical Trials Unit has liver clinical trials recruiting. Protocol: BIO89-100-132 (PI: DR Darrell Crawford) Protocol Title: A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)...
The GMR Clinical Trials Unit is currently recruiting for the following clinical trials in general oncology: PROTOCOL: HMBD-001-103 (PI: Dr Rahul Ladwa) - NOT YET RECRUITING Protocol Title: A Phase 1b Study to Evaluate HMBD-001 in Combination with Docetaxel with or without Cetuximab in Participants with...
Currently recruiting gastro-intestinal trials Protocol: AMT-676-01 (PI: DR Warren Joubert) Protocol Title: First-in-Human, Phase 1 Study of AMT-676, an Anti CDH17 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors Lay Title: AMT-676 in Patients With Advanced Solid Tumors Click here...
The GMR Clinical Trials Unit will soon be recruiting for the following lung clinical trial: protocol: CA245-0001 (PI: Dr Kenneth O’Byrne) - Not yet recruiting Protocol Title: A Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + Nivolumab Fixed Dose Combination)...
The GMRF Clinical Trials Unit is currently recruiting for the following melanoma trials: PROTOCOL: IOV-MEL-301 (TILVANCE-301) (PI: DR VICTORIA ATKINSON) Protocol Title: A Phase 3, multicenter, randomized, open-label, parallel group, treatment study to assess the efficacy and safety of the lifileucel...
The GMRF Clinical Trials Unit is currently recruiting for the following clinical trials in genitourinary cancer: protocol: MK2870-022 (PI: Dr. Jeffrey Goh) - Not yet recruiting Protocol Title: A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan...
The GMR Clinical Trials Unit is not currently recruiting any clinical trials in Haematology.
The GMR Clinical Trials Unit is currently recruiting for the following clinical trials in respiratory illness: protocol: mkc-ci-002 (PI: dr rachel thomson) Protocol Title: ICoN-1: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Efficacy and Safety of Clofazimine Inhalation Suspension...
There are no studies currently recruiting for infectious diseases